tyrosyl-prolyl-leucyl-glycinamide has been researched along with Drug Withdrawal Symptoms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benson, TM; Corriere, LS; Handunge, BP; Kastin, AJ; Lake, JR; Leyva, JE; Malin, DR; Rogillio, RB; Zadina, JE | 1 |
| Banks, WA; Cohn, CS; Kastin, AJ; Plotkin, SR | 1 |
2 other study(ies) available for tyrosyl-prolyl-leucyl-glycinamide and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Tyr-MIF-1 precipitates abstinence syndrome in morphine-dependent rats.
Topics: Animals; Humans; Infant, Newborn; Male; Morphine; Morphine Dependence; MSH Release-Inhibiting Hormone; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 1993 |
Withdrawal from alcohol in withdrawal seizure-prone and -resistant mice: evidence for enkephalin resistance.
Topics: Aluminum; Animals; Brain Chemistry; Central Nervous System Depressants; Digoxigenin; Enkephalin, Methionine; Enkephalins; Ethanol; Female; Half-Life; Mice; Mice, Inbred Strains; MSH Release-Inhibiting Hormone; Neuropeptides; Protein Precursors; Radioimmunoassay; RNA, Messenger; Seizures; Substance Withdrawal Syndrome | 2001 |